CAR T-Cell Therapy Targets Cells That Cause Leukemia Relapse - Technology Networks

In a study, genetically engineered immune cells successfully targeted the specific cancer cells that may be responsible for the relapse of acute myeloid leukemia.

Genetically engineered immune cells successfully target the specific cancer cells that may be responsible for relapse of acute myeloid leukemia (AML), a type of blood cancer, and proved effective in … [+3820 chars]

full article...